ATS Medical, Inc. (NASDAQ: ATSI) is focused on providing novel products and services designed specifically for cardiac surgery. Over 160,000 ATS Open Pivot(R) Heart Valves have been implanted in patients around the globe. ATS’ 3f(R) brand includes multiple tissue heart valve product offerings at varying steps from market introductions and clinical trials to development projects that utilize less invasive valve replacement technology. For further information, visit the Company’s web site at www.atsmedical.com.
- 17 years ago
QualityStocks
ATS Medical, Inc. (NASDAQ: ATSI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Micropolis Holding Co. (NYSE American: MCRP) Signs MoU with SEE Holding to Power Global Expansion of Sustainable City 2.0
Micropolis (NYSE American: MCRP), a UAE-based leader in robotics and AI, has signed a non-legally…
-
QualityStocksNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Adjourns Special Meeting Due to Lack of Quorum
TransCode Therapeutics (NASDAQ: RNAZ) announced that its April 21 special meeting has been adjourned to…
-
Soligenix Inc. (NASDAQ: SNGX) HyBryte(TM) Paves Way for Breakthrough Treatment for Rare Skin Cancer
The global rare disease treatment market was estimated at $195.2 billion in 2024 and is…